Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy

被引：0
|
作者：
Balázs Ács
Veronika Zámbó
Laura Vízkeleti
A. Marcell Szász
Lilla Madaras
Gyöngyvér Szentmártoni
Tímea Tőkés
Béla Á. Molnár
István Artúr Molnár
Stefan Vári-Kakas
Janina Kulka
Anna-Mária Tőkés
机构：
[1] Semmelweis University,2nd Department of Pathology
[2] Semmelweis University,MTA
[3] MTA-TTK Lendület Cancer Biomarker Research Group,SE
[4] Semmelweis University,NAP Brain Metastasis Research Group
[5] Semmelweis University,Department of Clinical Oncology
[6] University of Oradea,1st Department of Surgery
[7] Romania,MTA
[8] Faculty of Electrical Engineering and Information Technology,SE Tumor Progression Research Group
[9] Semmelweis University,undefined
[10] 2nd Department of Pathology,undefined
来源：
Diagnostic Pathology | / 12卷
关键词：
Breast; Neoadjuvant chemotherapy; Ki-67; Predictive and prognostic markers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer
    Oshima, CTF
    Iriya, K
    Forones, NM
    NEOPLASMA, 2005, 52 (05) : 420 - 424
  • [32] Prognostic and predictive value of Ki-67 in triple-negative breast cancer
    Wang, Wei
    Wu, Jiayi
    Zhang, Peifeng
    Fei, Xiaochun
    Zong, Yu
    Chen, Xiaosong
    Huang, Ou
    He, Jian-Rong
    Chen, Weiguo
    Li, Yafen
    Shen, Kunwei
    Zhu, Li
    ONCOTARGET, 2016, 7 (21) : 31079 - 31087
  • [33] The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
    Xiuzhi Zhu
    Li Chen
    Binhao Huang
    Yue Wang
    Lei Ji
    Jiong Wu
    Genhong Di
    Guangyu Liu
    Keda Yu
    Zhimin Shao
    Zhonghua Wang
    Scientific Reports, 10
  • [34] The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
    Zhu, Xiuzhi
    Chen, Li
    Huang, Binhao
    Wang, Yue
    Ji, Lei
    Wu, Jiong
    Di, Genhong
    Liu, Guangyu
    Yu, Keda
    Shao, Zhimin
    Wang, Zhonghua
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [35] Changes in Apparent Diffusion Coefficient as Surrogate Marker for Changes in Ki-67 Index Due to Neoadjuvant Chemotherapy in Patients with Invasive Breast Cancer
    Luo, Ningbin
    Ji, Yinan
    Huang, Xiangyang
    Liu, Yu
    Liu, Lidong
    Jin, Guanqiao
    Zhao, Xin
    Zhu, Xuna
    Su, Danke
    ACADEMIC RADIOLOGY, 2019, 26 (10) : 1352 - 1357
  • [36] Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer
    Brown, Jason R.
    DiGiovanna, Michael P.
    Killelea, Brigid
    Lannin, Donald R.
    Rimm, David L.
    LABORATORY INVESTIGATION, 2014, 94 (01) : 98 - 106
  • [37] Ki-67 Change in Anthracyline-containing Neoadjuvant Chemotherapy Response in Breast Cancer
    Zi-guo Yang
    Le-hao Ren
    Feng Wang
    Pi-lin Wang
    Wen-yan Wang
    Shu-ye Lin
    Current Medical Science, 2024, 44 : 156 - 167
  • [38] Ki-67 Change in Anthracyline-containing Neoadjuvant Chemotherapy Response in Breast Cancer
    Yang, Zi-guo
    Ren, Le-hao
    Wang, Feng
    Wang, Pi-lin
    Wang, Wen-yan
    Lin, Shu-ye
    CURRENT MEDICAL SCIENCE, 2024, 44 (01) : 156 - 167
  • [39] Proliferation marker Ki-67 in early breast cancer
    Urruticoechea, A
    Smith, IE
    Dowsett, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 7212 - 7220
  • [40] Ki-67, an elusive marker in the prognosis of breast cancer
    Sood, Neelam
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2019, 150 (03) : 214 - 216
12345